Reaction
Diabetes Mellitus Non-Insulin-Dependent reporting signals
As of the last recalculation, Diabetes Mellitus Non-Insulin-Dependent appears in 1,454 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is OLANZAPINE PAMOATE (PRR 330.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Olanzapine Pamoate | 573 | 330.1 | 334.8 |
| Olanzapine | 594 | 133.1 | 133.8 |
| Ziprasidone Mesylate | 42 | 43.4 | 43.5 |
| Ziprasidone | 46 | 38.6 | 38.7 |
| Gemfibrozil | 33 | 31.8 | 31.9 |
| Lithium Carbonate | 34 | 29.3 | 29.4 |
| Divalproex Sodium | 82 | 26.7 | 26.7 |
| Amlodipine Besylate And Benazepril Hydrochloride | 17 | 26.7 | 26.7 |
| Paroxetine Hydrochloride | 87 | 14.5 | 14.5 |
| Glyburide | 24 | 14.4 | 14.4 |
| Losartan Potassium And Hydrochlorothiazide | 11 | 13.7 | 13.7 |
| Captopril | 9 | 13.5 | 13.5 |
| Quinine | 8 | 13.4 | 13.4 |
| Tolterodine Tartrate | 8 | 12.8 | 12.8 |
| Risperidone | 107 | 12.4 | 12.4 |
| Quetiapine | 144 | 11.8 | 11.8 |
| Cyclobenzaprine Hydrochloride | 7 | 11.2 | 11.2 |
| Raloxifene Hydrochloride | 10 | 9.9 | 9.9 |
| Abacavir Sulfate | 6 | 8.8 | 8.9 |
| Glipizide | 35 | 8.4 | 8.4 |
| Estrogens, Conjugated | 33 | 8.1 | 8.1 |
| Conjugated Estrogens | 32 | 8.0 | 8.0 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 11 | 6.7 | 6.7 |
| Loratadine And Pseudoephedrine Sulfate | 3 | 5.4 | 5.4 |
| Hydrocodone Bitartrate | 9 | 3.0 | 3.0 |